Table 2.
Established population-based screening and monitoring studies in early-stage type 1 diabetes
| Acronym | Study name/description |
|---|---|
| ASK | Autoimmunity Screening for Kids program (7) |
| BABYDIAB | Part of the international Type 1 Data Intelligence (T1DI) project (156) |
| DAISY | Diabetes Autoimmunity Study in the Young (6) |
| DIPP | Type 1 Diabetes Prediction and Prevention Study based in Finland (11) |
| DPT-1 | Diabetes Prevention Trial–Type 1 (12) |
| ENDIT | European Nicotinamide Diabetes Intervention Trial (13) |
| Fr1da | Population-based health care research study based in Bavaria, Germany (9) |
| INNODIA | Global partnership between academic institutions, commercial partners, and patient organizations (14) |
| PLEDGE | Population Level Estimation of T1D Risk Genes in Children (155) |
| TEDDY | The Environmental Determinants of Diabetes in the Young study (5) |
| Type 1 Diabetes TrialNet | International research network centered on delaying or preventing T1D (10) |
| Type1Screen | Australian screening and monitoring program open to relatives of individuals with type 1 diabetes and IAb+ people identified through other screening pathways (ANZCTR registration no. ACTRN12620000510943) |
Note that major research networks are included in the table, but this is not an exhaustive list.
ANZCTR, Australian New Zealand Clinical Trials Registry.